R
Rockwell Medical Inc (RMTI)
Official siteHEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ
$6.76
-0.27 (-3.84%)
Market Cap: $27.92M
Last updated: Nov 17, 2026 at 11:05 AM ET
Rockwell Medical Inc (RMTI) Valuation Multiples
Rockwell Medical (RMTI) trades at 0.4x sales and 0.8x book value. Its P/S of 0.4x is below its 5-year median of 0.5x. Its forward P/E is 19.5x.
Current Multiples
Its free cash flow yield is 3.1%.
| Multiple | Value |
|---|---|
| P/E (trailing) | N/A |
| Forward P/E | 19.5x |
| Price to sales | 0.4x |
| Price to book | 0.8x |
| Price to FCF | 32.4x |
| EV/FCF | 30.5x |
| PEG | N/A |
| FCF yield | 3.1% |
Historical Medians
Against its 10-year medians, its P/S is 50.0% below 0.8x and its P/B is 80.5% below 4.1x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/S | 0.4x | 0.5x | 0.8x |
| P/B | 0.8x | 1.4x | 4.1x |
Valuation History
Over the 9 of the 10 year ends shown that have a P/S, its P/S ranged from 0.2x in 2022 to 8.2x in 2016.
| Year end | Price | P/S | P/B |
|---|---|---|---|
| 2025 | $8.34 | 0.4x | 0.9x |
| 2024 | $20.40 | 0.6x | 2.1x |
| 2023 | $18.90 | 0.7x | 2.5x |
| 2022 | $10.15 | 0.2x | 0.8x |
| 2021 | $45.10 | 0.8x | N/A |
| 2020 | $111.11 | 1.1x | 2.1x |
| 2019 | $268.43 | N/A | 7.7x |
| 2018 | $248.62 | 6.0x | 100.6x |
| 2017 | $640.26 | 6.7x | 8.9x |
| 2016 | $720.57 | 8.2x | 6.3x |
Frequently Asked Questions About RMTI
What is RMTI's forward P/E ratio?
Rockwell Medical has a forward P/E ratio of 19.5x.
What is RMTI's price to sales ratio?
Rockwell Medical has a price to sales ratio of 0.4x.
RMTI pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts